Bak, Michiel Thomas Jan
van Ruler, Oddeke
Stassen, Laurents
Ruiterkamp, Marit
Arkenbosch, Jeanine Hubertina Catharina
Dijkstra, Gerard
Campmans-Kuijpers, Maria Johanna Elisabeth
van Meeteren, Nico Leonard Ulrich
Bongers, Bart Chateau
Romberg-Camps, Mariëlle
van der Marel, Sander
Hoentjen, Frank
van Dongen, Koen Willem
West, Rachel
van der Woude, Janneke
de Vries, Annemarie Charlotte
,
Article History
Accepted: 18 September 2023
First Online: 19 October 2023
Declarations
:
: Michiel Thomas Jan Bak, Marit Ruiterkamp, Jeanine Hubertina Catharina Arkenbosch, Maria Johanna Elisabeth Campmans-Kuijpers, Nico Leonard Ulrich van Meeteren, Bart Chateau Bongers, Mariëlle Romberg-Camps, Sander van der Marel en Koen Willem van Dongen have no disclosures. Oddeke van Ruler has served as invited speaker for Janssen-Cilag and has received non-financial support from Takeda outside the submitted work. Laurents Stassen has served as a speaker and received research support from Takeda, outside the submitted work. Gerard Dijkstra has received a grant from Royal DSM and speaker fees from: Abbvie, Janssen-Cilag, Takeda and Pfizer. Frank Hoentjen has served on advisory boards or as speaker for Abbvie, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz and Dr Falk, and has received funding (grants/honoraria) from Dr Falk, Janssen-Cilag, Abbvie, Takeda and consulting fees from Celgene and Janssen-Cilag, all outside the submitted work. Rachel West has served on the advisory board and as invited speaker for Janssen, Pfizer, Takeda and Galapagos outside the submitted work. Janneke van der Woude received grants and or fee for advisory boards and presentations from Pfizer, Abbvie, Celltrion, Falk Benelux, Takeda, Janssen and Ferring outside the submitted work. Annemarie Charlotte de Vries has served on advisory boards for Takeda, Janssen, Bristol Myers Squibb, Abbvie, Pfizer, and Galapagos and has received unrestricted research grants from Takeda, Janssen, and Pfizer outside the submitted work.